AHA Reply Brief in Case to Prevent Disclosure of Negotiated Contracts (Feb. 28, 2020)

AHA reply brief in case to prevent disclosure of negotiated contracts (Feb. 28, 2020).

Related Resources

Letter/Comment
Public
Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to…
Special Bulletin
Public
The United States Supreme Court this morning rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did…
Advisory
Member
The hospital price transparency rule took effect Jan. 1, 2021. CMS verified for the AHA that the agency has begun proactive audits of hospital websites and a…
Letter/Comment
Member
AHA urges the Centers for Medicare & Medicaid Services to align the Hospital Price Transparency Rule with new transparency requirements included in the No…
Fact Sheets
Public
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Letter/Comment
Public
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.